Helios is an at-home, needle-free blood test that measures more than 1,000 proteins, with an AI health coach. Waitlist open; launches in 2027.
About Helios
Helios is a health testing company, not a creator tool. Its at-home test measures more than 1,000 proteins from a single drop of blood, which you collect yourself with a painless, needle-free device. The Helios AI Health Coach turns the results into an explanation, highlights risks, and suggests personalized steps.
Helios came out of stealth in November 2026 and opened a waitlist for consumers and clinicians at myhelios.com. The test launches in 2027. Helios's YC launch says it is starting with a small cohort of clinics, that people on the waitlist get first access, and that results come back in 2 to 4 weeks.
Helios says studies have linked blood proteins to more than 600 diseases, decades before diagnosis. Its FAQ says scores are meant to support clinical judgment and are not diagnoses, and a physician decides what to act on.
Helios was founded by Omar Abudayyeh, Jonathan Gootenberg and Yousef Badran, M.D. It is backed by Y Combinator (F26) and Formation VC. Pricing has not been announced. Checked November 18, 2026 at myhelios.com.
Pricing: Pricing has not been announced. The waitlist is open now, and the test launches in 2027.
Features
- At-home collection of a single drop of blood with a needle-free device
- Measures more than 1,000 proteins
- Helios AI Health Coach explains results, highlights risks and suggests personalized steps
- Results in 2 to 4 weeks, according to its YC launch
- Waitlist open for consumers and clinicians; the test launches in 2027
- Scores support clinical judgment and are not diagnoses
FAQs
Common questions about Helios




